Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
Paula de Michelena, Ignacio Torres, Ángela Ramos-García, Victoria Gosalbes, Nidia Ruiz, Ana Sanmartín, Pilar Botija, Sandrine Poujois, Dixie Huntley, Eliseo Albert, David Navarro
doi: https://doi.org/10.1101/2022.02.02.22270295
Paula de Michelena
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
Ignacio Torres
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
Ángela Ramos-García
2Health Care center Benimaclet, Health Department Clínico-Malvarrosa, Valencia, Spain
Victoria Gosalbes
3Health Care center Salvador Pau, Health Department Clínico-Malvarrosa, Valencia, Spain
Nidia Ruiz
4Health Care center Serrería, Health Department Clínico-Malvarrosa, Valencia, Spain
Ana Sanmartín
5Primary Health Directorate, Health Department Clínico-Malvarrosa, Valencia, Spain
Pilar Botija
5Primary Health Directorate, Health Department Clínico-Malvarrosa, Valencia, Spain
Sandrine Poujois
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
Dixie Huntley
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
Eliseo Albert
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
David Navarro
1Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain
6Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain
Data Availability
The data that support the findings of this study are available on request from the corresponding author
Posted February 02, 2022.
Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
Paula de Michelena, Ignacio Torres, Ángela Ramos-García, Victoria Gosalbes, Nidia Ruiz, Ana Sanmartín, Pilar Botija, Sandrine Poujois, Dixie Huntley, Eliseo Albert, David Navarro
medRxiv 2022.02.02.22270295; doi: https://doi.org/10.1101/2022.02.02.22270295
Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
Paula de Michelena, Ignacio Torres, Ángela Ramos-García, Victoria Gosalbes, Nidia Ruiz, Ana Sanmartín, Pilar Botija, Sandrine Poujois, Dixie Huntley, Eliseo Albert, David Navarro
medRxiv 2022.02.02.22270295; doi: https://doi.org/10.1101/2022.02.02.22270295
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)